Nonalcoholic Fatty Liver Disease (NASH)
Living with NASH?
We’re conducting a study to see how we can help improve liver health in people with NASH and advanced (F3) fibrosis. The study will last for about 76 weeks, including the screening time. The treatment will take up to 52 weeks. Your participation could make a real difference!
To qualify, you must be:
- 18-75 years old
- Have a liver biopsy at baseline
- Able and willing to comply with all study assessments, including a liver biopsy at Week 52
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.